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CASE REPORT Open Access
Ocular rhinosporidiosis mimicking conjunctival
squamous papilloma in Kenya – a case report
Stephen Gichuhi1,2*, Timothy Onyuma3, Ephantus Macharia4, Joy Kabiru4, Alain M’bongo Zindamoyen4,
Mandeep S Sagoo5,6 and Matthew J Burton2,5
Abstract
Background: Ocular rhinosporidiosis is a chronic granulomatous infection caused by a newly classified organism
that is neither a fungus nor bacterium. It often presents as a benign conjunctival tumour but may mimic other
ocular conditions. It is most often described in India. In Africa cases have been reported from South Africa, Kenya,
Tanzania, Malawi, Uganda, Congo and Ivory Coast.
Case presentation: A 54 year old man was seen in Kenya with a lesion that resembled a conjunctival papilloma.
We report resemblance to conjunctival papilloma and the result of vital staining with 0.05% Toluidine Blue.
Conclusion: Ocular rhinosporidiosis occurs in East Africa. It may resemble conjunctival squamous papilloma. Vital
staining with 0.05% Toluidine blue dye did not distinguish the two lesions well.
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Background
Rhinosporidiosis is a chronic granulomatous infection of
the mucous membranes (nasal, oral, ocular and rectal)
caused by Rhinosporidium seeberi [1]. This is an unusual
unicellular pathogen that is difficult to culture and
whose taxonomic classification has been controversial. It
has been variously hypothesized to be a cyanobacterium
(prokaryote), a eukaryotic Mesomycetozoa or a fungus
[2]. Currently it is domiciled in the Mesomycetozoea
class (also known as the DRIP clade, or Ichthyosporea).
The term Mesomycetozoea derives from “Meso-” (in the
middle of ), “-myceto-” (fungi) and “-zoea” (animals).
This is a heterogeneous group of microorganisms at the
animal-fungal boundary. The Mesomycetozoea are a
small group of protists, which are mostly parasites of
fish and other animals.
Rhinosporidiosis affects both adults and children and
is commonly seen in otolaryngology. The largest re-
ported case series of rhinosporidiosis consisting of 462
cases in India found that the disease mainly occurs in
the nose and nasopharynx (81.1%) while the eye was af-
fected in 14.2% [3]. Another series of 34 cases from
India also found nasal and nasopharyngeal involvement
in 85% while the eye was affected in 9% of cases [4]. A
case involving multiple parts of the body; the nares, mul-
tiple areas of the skin, the external urethral meatus,
glans of penis and the perineum has been reported in
India [5].
Ocular rhinosporidiosis affecting the conjunctiva was
first described in India in 1912 [6]. Currently most pub-
lished reports on rhinosporidiosis of the eye have been
reported from Asia mainly from India, Sri Lanka, Nepal
and Bangladesh. In Africa it has been reported in South
Africa, Malawi, Zambia, Kenya, Uganda, Tanzania,
Congo, Ivory Coast, and Cameroon [7-13]. None of the
cases in Africa were initially diagnosed as ocular rhinos-
poridiosis, perhaps a sign of its rarity.
How the disease is acquired remains an enigma. Rhi-
nosporidiosis has been associated with migrants from
endemic areas [14-16]. Although it is an infectious dis-
ease, as lesions are always associated with the presence
of the pathogen, there is limited data on how it might be
transmitted [15]. It is presumed to be acquired through
traumatized nasal mucosa and spread to other sites by
autoinoculation. As most rhinosporidiosis lesions arise
from the nose, it is feasible that ocular involvement may
occur by spreading from the nose through the lacrimal
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sac to the plica of the conjunctiva. This hypothesis is
however unproven.
Ocular rhinosporidium most often presents as a polypoid
mass of the palpebral conjunctiva [17]. It may also present
as a lacrimal sac diverticulum [18], recurrent chalazion
[19], conjunctival cyst [20], chronic follicular conjunctivitis
in contact lens wearers [21], peripheral keratitis [22], scleral
melting [23], ciliary staphyloma [24] or simulate a tumour
of the eyelid [25] or periorbital skin [26]. Large conjunc-
tival lesions may cause mechanical ectropion [27]. Lacrimal
sac disease may present with bloody tears [16].
In a series of 63 cases from India that included nasal,
nasopharyngeal and ocular disease, routine haematology
tests did not show any abnormality and while cytology
of smears obtained via fine needle aspiration or cytology
has a role in diagnosis, the mainstay remains histology
[28]. Vital staining with Toluidine blue has been de-
scribed for diagnosis of conjunctival tumours but not for
rhinosporidiosis [29].
The treatment is surgical excision with or without cau-
tery at the base and recurrence is described as rare [30].
Scleral melting may be treated with a tectonic corneal graft
[31]. There are reports that the following agents are effect-
ive in vivo: imidocarb diproprionate, diminazine aceturate,
cycloserine, dapsone, trimethoprim-suphadiazine, ketoco-
nazole, sodium stibogluconate, and amphotericin B [32].
Dapsone is the most commonly reported drug and com-
bination therapy to prevent drug resistance is recom-
mended. A laboratory study in India found that biocides
Figure 1 Pre-operative clinical photographs. A & B – shows the ocular rhinosporidiosis lesion in the region of the right medial canthus.
C & D - shows squamous papilloma in the left medial canthus area from another patient for comparison. Both lesions are shown before and after
vital staining with 0.05% Toluidine Blue.
Figure 2 Photomicrograph of ocular rhinosporidiosis stained
with Haematoxylin & Eosin (H & E ×10) showing multiple
sporangia within the conjunctival stroma (block arrows).
Figure 3 Multiple sporangia with a reactive mixed
inflammatory cell infiltrate (H & E ×20).
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including hydrogen peroxide, glutaraldehyde, chloroxyle-
nol, chlorhexidine, cetrimide, thimerosal, 70% ethanol, iod-
ine in 70% ethanol, 10% formalin, povidone-iodine, sodium
azide and silver nitrate caused metabolic inactivation with
or without altered structural integrity of the endoconidia of
Rhinosporidium seeberii but no human trials have been
reported [33]. Human anti-rhinosporidial antibody is not
directly protective against the endoconidia [34].
Case presentation
A 54-year-old male presented to the eye clinic at the
PCEA Kikuyu Hospital on the outskirts of Nairobi with
a 16 month history of a painless lump on the surface of
the right eye. Concerned about the appearance, he at-
tributed the lesion to a foreign body that entered that
eye while he was trimming a hedge.
No other family member or neighbour had a similar dis-
ease. Social history included living in Homa Bay district
on the shores of Lake Victoria from birth to 18 years age,
then Kapsabet, a highland area in the Rift Valley until the
age of 26 years, followed by Nairobi. He had resided in a
low-income area of Nairobi for the past 11 years. Occupa-
tional history included working as a gardener for the last
10 years and a cook for 5 years prior to that. Although he
grew up in a lakeside area, he had not dived or swum in
stagnant water in the recent past.
On examination he had a pedunculated 6×11 mm wide
fleshy mass at the medial canthus of the right eye (Figure 1),
which was pink with some intrinsic pigmentation. It had a
papilliform surface with vascular tufts and some epithelial
ulceration. There was no discharge or conjunctival injec-
tion. The mass was not attached to the lid but arose from
the plica semilunaris. On vital staining with 0.05%
Toluidine Blue it was coloured deep blue except at the
ulcerated surface, similar to the staining of a papilloma.
The clinical diagnosis was of conjunctival papilloma and
surgical excision under local anaesthetic was undertaken.
Histological analysis revealed multiple sporangia in the
conjunctival stroma, an ulcerated squamous epithelium
covered by a fibrin plaque whose underlying tissue
showed granulomatous tissue, mixed inflammatory cells
Figure 4 Sporangium at higher magnification filled with
endoconidia and surrounded by plasma cells and lymphocytes
(H & E ×40).
Figure 6 Ulcerated surface epithelium (open arrows) with a
fibrin plaque and granulation tissue on the basal side of the
ulcer (H & E ×20).
Figure 5 Burst sporangium with discharged microsporangia
surrounded by an inflammatory cell infiltrate (H & E ×40).
Figure 7 Post-operative photographs showing no recurrence
6 months after excision of ocular rhinosporidiosis.
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with lymphocytes showing a maturation spectrum and
numerous thick walled sporangia filled with nucleated
basophilic endoconidia (Figures 2, 3, 4, 5 and 6). A diag-
nosis of ocular rhinosporidiosis was made.
There was no recurrence 6 months after excision was
performed (Figure 7).
Conclusions
Ocular rhinosporidiosis occurs in East Africa. It may re-
semble conjunctival squamous papilloma. Although tolui-
dine blue has been used as a vital stain of conjunctival
lesions, in this case, it was unable to distinguish between
an infective and neoplastic cause.
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